Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AD Phenothiazine derivatives
R06AD07 Mequitazine
D01324 Mequitazine (JP19/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
44 Allergic agents
441 Antihistamines
4413 Phenothiazines
D01324 Mequitazine (JP19/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for nervous and sensory systems
01 Cold remedy (oral use)
D01324 Mequitazine (JP19/INN)
Allergic agents
52 Antihistamine based drugs
D01324 Mequitazine (JP19/INN)
Agents for otolaryngologic use
69 Oral medicine for nasal inflammation
D01324 Mequitazine (JP19/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Mequitazine
D01324 Mequitazine (JP19/INN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
D01324 Mequitazine
Dermatological agent
DG03243 Atopic dermatitis agent
D01324 Mequitazine
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
D01324 Mequitazine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D01324 Mequitazine (JP19/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01324 Mequitazine
D01324 Mequitazine tablets
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01324
Rx-to-OTC switch list in Japan [br08314.html]
D01324
